MX354579B - Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. - Google Patents
Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres.Info
- Publication number
- MX354579B MX354579B MX2014007523A MX2014007523A MX354579B MX 354579 B MX354579 B MX 354579B MX 2014007523 A MX2014007523 A MX 2014007523A MX 2014007523 A MX2014007523 A MX 2014007523A MX 354579 B MX354579 B MX 354579B
- Authority
- MX
- Mexico
- Prior art keywords
- release
- active principle
- women
- modulating
- continuous
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001929 meloxicam Drugs 0.000 title abstract 3
- 229940044953 vaginal ring Drugs 0.000 title abstract 3
- 239000006213 vaginal ring Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000003433 contraceptive agent Substances 0.000 title abstract 2
- 230000002254 contraceptive effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere al Anillo vaginal de liberación sostenida que comprende meloxicam y un agente modulador de la liberación del principio activo, tal como polivinilpirrolidona K-30, que libera el principio activo por al menos 90 días, útil como anticonceptivo de uso continuo en mujeres. El anillo vaginal comprende preferentemente 5% a 30% en peso de meloxicam, en relación al peso total de la formulación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/056022 WO2013098591A1 (es) | 2011-12-29 | 2011-12-29 | Anillo vaginal que comprende meloxicam y un agente modulador de la liberación del principio activo, útil como anticonceptivo de uso continuo en mujeres |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007523A MX2014007523A (es) | 2014-08-27 |
| MX354579B true MX354579B (es) | 2018-03-12 |
Family
ID=48696404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007523A MX354579B (es) | 2011-12-29 | 2011-12-29 | Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9533050B2 (es) |
| EP (1) | EP2799043B1 (es) |
| JP (1) | JP5902318B2 (es) |
| KR (1) | KR101785414B1 (es) |
| CN (1) | CN104203169B (es) |
| BR (1) | BR112014015053A2 (es) |
| CA (1) | CA2860108C (es) |
| EA (1) | EA027564B1 (es) |
| MX (1) | MX354579B (es) |
| NI (1) | NI201400066A (es) |
| WO (1) | WO2013098591A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20155779A7 (fi) | 2015-10-30 | 2017-05-01 | Solani Therapeutics Ltd | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
| EP3272333A1 (en) | 2016-07-22 | 2018-01-24 | Chemo Research, S.L. | Vaginal composition comprising a combination of estrogen and vitamin d |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997031631A1 (en) | 1996-02-27 | 1997-09-04 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
| DE19608423A1 (de) | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Implantate mit phasenweiser Arzneistoffabgabe |
| US6197327B1 (en) | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
| US6905701B2 (en) * | 1997-06-11 | 2005-06-14 | Umd, Inc. | Formulations for transmucosal vaginal delivery of bisphosphonates |
| US20050276836A1 (en) * | 1997-06-11 | 2005-12-15 | Michelle Wilson | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents |
| IL157771A0 (en) * | 2001-03-27 | 2004-03-28 | Galen Chemicals Ltd | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| US7004171B2 (en) | 2002-02-25 | 2006-02-28 | Hi-Gienic Intra Vaginal Technologies Ltd. | System for transvaginal drug delivery |
| KR20040092649A (ko) | 2003-04-24 | 2004-11-04 | 엘지전자 주식회사 | 광디스크의 복사 방지 정보 관리방법 |
| JP5017109B2 (ja) * | 2004-07-09 | 2012-09-05 | ザ・ポピュレイション・カウンシル，インコーポレイテッド | プロゲステロン受容体モジュレーターを含有する徐放性組成物 |
| DE102006027793A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Opioid-Kombinations-Wafer |
| JP2009541360A (ja) * | 2006-06-23 | 2009-11-26 | エラン・ファルマ・インターナショナル・リミテッド | ナノ粒子状メロキシカムおよび制御放出ヒドロコドンを含む組成物 |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
| WO2010009335A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
-
2011
- 2011-12-29 EP EP11879093.0A patent/EP2799043B1/en not_active Not-in-force
- 2011-12-29 CA CA2860108A patent/CA2860108C/en not_active Expired - Fee Related
- 2011-12-29 CN CN201180076297.4A patent/CN104203169B/zh not_active Expired - Fee Related
- 2011-12-29 JP JP2014549543A patent/JP5902318B2/ja not_active Expired - Fee Related
- 2011-12-29 MX MX2014007523A patent/MX354579B/es active IP Right Grant
- 2011-12-29 BR BR112014015053A patent/BR112014015053A2/pt not_active Application Discontinuation
- 2011-12-29 WO PCT/IB2011/056022 patent/WO2013098591A1/es not_active Ceased
- 2011-12-29 US US14/367,678 patent/US9533050B2/en not_active Expired - Fee Related
- 2011-12-29 EA EA201491167A patent/EA027564B1/ru not_active IP Right Cessation
- 2011-12-29 KR KR1020147020217A patent/KR101785414B1/ko not_active Expired - Fee Related
-
2014
- 2014-06-20 NI NI201400066A patent/NI201400066A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014007523A (es) | 2014-08-27 |
| BR112014015053A2 (pt) | 2017-06-13 |
| EA201491167A1 (ru) | 2014-12-30 |
| JP5902318B2 (ja) | 2016-04-13 |
| EA027564B1 (ru) | 2017-08-31 |
| NI201400066A (es) | 2017-03-13 |
| EP2799043A4 (en) | 2015-08-05 |
| US9533050B2 (en) | 2017-01-03 |
| EP2799043A1 (en) | 2014-11-05 |
| CA2860108C (en) | 2016-10-04 |
| CA2860108A1 (en) | 2013-07-04 |
| CN104203169A (zh) | 2014-12-10 |
| EP2799043B1 (en) | 2019-11-27 |
| CN104203169B (zh) | 2016-07-13 |
| US20150328319A1 (en) | 2015-11-19 |
| JP2015503544A (ja) | 2015-02-02 |
| KR101785414B1 (ko) | 2017-10-16 |
| WO2013098591A1 (es) | 2013-07-04 |
| KR20140112040A (ko) | 2014-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX392839B (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| MX2012015187A (es) | Metodo para suministrar un agente activo. | |
| EA201291372A1 (ru) | Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия | |
| MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
| NZ602111A (en) | Extended release formulations of rasagiline and uses thereof | |
| CU24065B1 (es) | Forma de dosificación farmacéutica que comprende nifedipino y un antagonista de angiotensina ii | |
| IN2012MN02923A (es) | ||
| IN2014KN02324A (es) | ||
| MX2013001677A (es) | Formulaciones estables de linaclotida. | |
| MY191875A (en) | Solid dosage form | |
| PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
| MY159492A (en) | Solid pharmaceutical formulation with delayed release | |
| NZ714288A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| MD4563B1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| TN2015000135A1 (en) | Modified release formulations for oprozomib | |
| EA201500375A1 (ru) | Композиция для ухода за ротовой полостью | |
| MX2013012364A (es) | Composicion y metodo para mejorar la estabilidad fisica de formulaciones agricolas en suspension basadas en aceite. | |
| AR095691A1 (es) | FORMULACIÓN DE L-5-METILTETRAHIDROFOLATO DE CALCIO AMORFO (L-5-MTHF-Ca), PROCEDIMIENTO, USO | |
| WO2012064302A3 (en) | Improved montelukast formulations | |
| MX376014B (es) | Composicion para el cuidado bucal. | |
| MX2014007523A (es) | Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. | |
| MX359713B (es) | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. | |
| IN2014DN10134A (es) | ||
| IN2012CH05549A (es) | ||
| IN2014CN04119A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: LABORATORIOS ANDROMACO, S.A. (EX INVERSIONES GRUCH |
|
| FG | Grant or registration |